TET2 and acute myeloid leukemia: To evaluate the therapeutic potential of STING inhibition, we tested the effect of H-151 on colony formation of BM cells derived from 4 AML patients with TET2 mutations (P1-4) and 3 AML patients without TET2 mutations (P5-7) (Supplementary Fig. 8A).